Barbara Pistilli, MD

Articles by Barbara Pistilli, MD

Dr Pistilli on Understanding Dynamic HER2 Expression in Metastatic Breast Cancer

June 22nd 2023

Barbara Pistilli, MD, discusses the importance of understanding how HER2 expression can change over time when assessing target expression in metastatic breast cancer.

Latest Updated Articles

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma

2025 Data Across Gynecologic, Lung, and Hematologic Cancers Reshape Treatment Landscapes

Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC

HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts